|Bid||0.0810 x 19973700|
|Ask||0.0880 x 27494300|
|Day's range||0.0810 - 0.0850|
|52-week range||0.0690 - 0.1350|
|Beta (5Y monthly)||0.19|
|PE ratio (TTM)||9.44|
|Earnings date||31 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
It is hard to get excited after looking at Regeneus' (ASX:RGS) recent performance, when its stock has declined 8.8...
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to announce a research collaboration with Professor Christopher Little and the Raymond Purves Bone and Joint Research Laboratory at the Kolling Institute at Royal North Shore Hospital, Australia.